Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The historical rank and industry rank for Synthetic MR AB's Pretax Margin % or its related term are showing as below:
XSAT:SYNT'
s Pretax Margin % Range Over the Past 10 Years
Min: -96.27 Med: 13.13 Max: 38.72
Current: -85.51
XSAT:SYNT's Pretax Margin % is ranked worse than 89.91% of 664
companies
in the Healthcare Providers & Services industry
Industry Median: 4.015
vs XSAT:SYNT: -85.51
Synthetic MR AB (XSAT:SYNT) Pretax Margin % Explanation
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
Synthetic MR AB Pretax Margin % Related Terms
Synthetic MR AB Pretax Margin % Historical Data
* Premium members only.
The historical data trend for Synthetic MR AB's Pretax Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XSAT:SYNT vs VEEV, BTSG, TEM: Pretax Margin % Comparison
For the Health Information Services subindustry, Synthetic MR AB's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Synthetic MR AB Pretax Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Synthetic MR AB's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where Synthetic MR AB's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Synthetic MR AB (XSAT:SYNT) has a Pretax Margin % of -46.64% as of Mar. 2026. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Synthetic MR AB and its competitors. According to the industry distribution chart, Synthetic MR AB ranks #597 out of 664 companies in the Healthcare Providers & Services industry, placing it in the top 89.9%.
Is Synthetic MR AB's Pretax Margin % too high?
Synthetic MR AB's current Pretax Margin % is -46.64%. Based on the distribution chart, Synthetic MR AB ranks #597 out of 664 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Synthetic MR AB has a GF Score™ of 63/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Synthetic MR AB's Pretax Margin % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Synthetic MR AB ranks #597 out of 664 companies for Pretax Margin %. This places Synthetic MR AB in the lower half of its industry. The industry median Pretax Margin % is 4.02. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Healthcare Providers & Services company?
The median Pretax Margin % among Healthcare Providers & Services companies is 4.02, based on 664 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Synthetic MR AB and its competitors. For the Healthcare Providers & Services industry, the median Pretax Margin % is 4.02 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Synthetic MR AB's current Pretax Margin % is -46.64%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Synthetic MR AB stock overvalued right now?
Based on GuruFocus' analysis, Synthetic MR AB (XSAT:SYNT) is currently considered Possible Value Trap. The stock's GF Value™ is kr4.59, compared to a current price of kr0.62 — trading 86.6% below its estimated fair value. The current Pretax Margin % is -46.64%. Synthetic MR AB's overall GF Score™ is 63/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For Synthetic MR AB (XSAT:SYNT), the current Pretax Margin % is -46.64% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Synthetic MR AB (XSAT:SYNT) Overvalued in 2026?
Based on GuruFocus' analysis, Synthetic MR AB stock appears to be undervalued.
The current stock price of kr0.62 is trading 86.6% below its estimated GF Value™ of kr4.59.
GuruFocus considers Synthetic MR AB to be Possible Value Trap.
Key valuation signals for XSAT:SYNT:
Pretax Margin %: -46.64%
GF Value™: kr4.59 vs. price of kr0.62 (86.6% below fair value)
No single metric tells the full story. See the XSAT:SYNT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Synthetic MR AB develops and markets software solutions that improve the efficiency of neuroimaging processes and diagnostic accuracy. SyntheticMR's SyMRI solution measures the brain's absolute tissue properties and generates multiple contrast-weighted images, performs automatic segmentation of biomarkers, and delivers quantitative data in a single rapid examination. Combinostics offers the AI-driven cNeuro product family, which helps clinicians make a difference in the lives of patients with neurological diseases. Geographically, the group operates in America, Europe, and APAC. The majority of its revenue is generated from Europe.
63GF Score
Get the complete analysis for XSAT:SYNT
Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSAT:SYNT has been successfully added to your 
